on MELANOMA
an EXPERIMENTAL Vaccine
has experimental results that
are promising to prevent the
recurrence / or death within
2 years . . .
2026/10/22/well/cancer-vaccine-
melanoma-merck-moderna.html
Findings released earlier than
expected; the companies announced
the extent of the trial (1,137 patients)
and information of the mRNA vaccine.
No comments:
Post a Comment